# OnCo record target-national (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/target-national/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "target-national", "NCT04723316" ;
  schema:name "TARGET National"@en ;
  schema:alternateName "TARGET"@en, "Tumour Characterisation to Guide Experimental Targeted Therapy"@en, "TARGET trial Manchester"@en ;
  schema:description "TARGET National is the United Kingdom's programme to sequence the blood and tumour of thousands of people with advanced cancer so they can be steered into early trials of drugs that fit their tumour's changes. It grew out of a Manchester pilot that showed a blood test alone could find a trial for one patient in ten."@en ;
  schema:url <https://onco.cc/trials/target-national/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04723316>, <https://doi.org/10.1038/s41591-019-0380-z> ;
  onco:status "recruiting" ;
  onco:phase "observational" ;
  schema:startDate "2021-06-30" ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/variant-knowledgebases/>, <https://onco.cc/technologies/ai-trial-matching/> ;
  onco:institutions <https://onco.cc/institutions/the-christie/>, <https://onco.cc/institutions/cruk-manchester-institute/>, <https://onco.cc/institutions/cruk/> ;
  onco:terms <https://onco.cc/terms/master-protocol/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/first-in-human/> ;
  onco:trials <https://onco.cc/trials/determine-trial/> ;
  onco:people <https://onco.cc/people/caroline-dive/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-enrolment/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-rothwell-nat-med/> .
